Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 07:49 PM EDT
Outlook Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
PE Ratio | -0.2 | 0.66 | 4.35 | 0.97 | -0.32 | -2.29 | -1.11 | -5.4 | -10.51 | -3.29 | -4.51 | -3.21 | -4.95 | -4.42 | -6.82 | -8.6 | -6.47 | -2.74 |
PEG Ratio | 0.00 | 0.00 | -0.05 | -0.01 | -0.00 | 0.16 | 0.03 | -0.03 | 0.16 | -0.18 | 0.29 | 0.29 | -0.4 | -7.03 | -0.5 | 0.44 | 0.24 | -0.33 |
PS Ratio | n/a | n/a | 582.23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -1.16 | -0.91 | -1.36 | -2.06 | -1.09 | -4.21 | -3.98 | -81.22 | 26.67 | 15.59 | 29.62 | 11.20 | 10.84 | 5.24 | 79.32 | 32.89 | 16.42 | -15.11 |
P/FCF Ratio | -2.27 | -4.18 | -5.83 | -8.84 | -7.6 | -7.87 | -4.51 | -33.82 | -34.48 | -27.59 | -25.24 | -10.66 | -27.2 | -23.28 | -40.65 | -20.77 | -28.87 | -11.88 |
P/OCF Ratio | -2.27 | -4.18 | -5.83 | -8.84 | -7.6 | -7.87 | -4.51 | -33.82 | -34.48 | -27.59 | -25.24 | -10.66 | -27.2 | -23.28 | -40.65 | -20.77 | -28.87 | -11.88 |
OCF/S Ratio | n/a | n/a | -99.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -1.03 | -0.62 | -0.41 | -0.39 | -0.33 | -1.5 | -2.46 | -6.31 | 3.04 | 2.02 | 1.25 | 0.52 | 0.64 | 0.46 | 2.58 | 0.92 | 0.55 | -1.08 |
Quick Ratio | 0.57 | 0.26 | 0.64 | 1.07 | 1.07 | 0.44 | 0.66 | 0.86 | 1.22 | 4.09 | 1.39 | 2.04 | 2.12 | 3.88 | 3.19 | 1.62 | 1.56 | 0.91 |
Current Ratio | 0.72 | 0.32 | 0.64 | 1.07 | 1.07 | 0.44 | 0.66 | 0.86 | 1.22 | 4.09 | 1.39 | 2.04 | 2.12 | 3.88 | 3.19 | 1.62 | 1.56 | 0.91 |
Asset Turnover | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -669.74 | n/a | n/a | n/a | -6.14 | n/a | n/a | -59.87K | n/a | -6.41 | -38.79 | -47.69 | -45.2 | -37.41 | -49.91 | -44.67 | -50.42 | -88.88 |
Return on Equity | 1.43 | -0.35 | -0.08 | -0.53 | 0.85 | 0.46 | 0.90 | 3.76 | -0.63 | -1.18 | -1.64 | -0.87 | -0.55 | -0.3 | -2.91 | -0.96 | -0.63 | 1.38 |
Return on Assets | -2.43 | 1.02 | 0.20 | 0.94 | -1.94 | -0.52 | -0.4 | -0.47 | -0.12 | -0.3 | -0.5 | -0.45 | -0.29 | -0.18 | -0.59 | -0.37 | -0.29 | -1.15 |
Return on Invested Capital | -1.96 | 49.72 | -1.45 | -0.53 | -0.38 | -0.84 | -0.59 | -0.62 | -0.16 | -0.33 | -0.71 | -0.56 | -0.32 | -0.18 | -0.79 | -0.46 | -0.39 | -14.35 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | 33.45 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | 33.45 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -134.47 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | 33.62 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |